Mueangpoon Kulpatsorn, Inchan Chapipak, Kaewmuneechoke Panithan, Rattana Peerunda, Budsratid Supanut, Japakiya Suthasinee, Ngamchaliew Pitchayanont, Vichitkunakorn Polathep
Faculty of Medicine, Prince of Songkhla University, Songkhla 90110, Thailand.
Department of Family and Preventive Medicine, Faculty of Medicine, Prince of Songkhla University, Songkhla 90110, Thailand.
Vaccines (Basel). 2022 Apr 16;10(4):627. doi: 10.3390/vaccines10040627.
This study aimed to estimate the prevalence and influencing factors of COVID-19 vaccine hesitancy and willingness to pay in Thailand. A descriptive cross-sectional study was conducted from 13 September 2021 to 14 January 2022. Data were collected using an online questionnaire consisting of demographic characteristics, COVID-19 vaccine hesitancy (delay in acceptance and denying vaccination), determinants of vaccine hesitancy (complacency, convenience, and confidence), and willingness to pay. The general Thai population aged ≥18 years were surveyed. Among 705 respondents, 10.4% reported hesitancy, with significant determinants being low complacency and confidence in the vaccine; low convenience was not a significant determinant. Multivariate analysis revealed vaccine hesitancy among women, those with higher education, non-healthcare workers, and those who lived in rural areas. Furthermore, 77.2% of respondents were willing to pay, with the majority willing to pay in the range of THB 501-1000 ( USD 1 = THB 33) per dose. Increased monthly income, no impact of COVID-19 on income, and time period (before mRNA vaccine availability) significantly affected willingness to pay.
本研究旨在评估泰国新冠疫苗犹豫情况及支付意愿的流行程度和影响因素。于2021年9月13日至2022年1月14日开展了一项描述性横断面研究。通过在线问卷收集数据，问卷内容包括人口统计学特征、新冠疫苗犹豫情况（延迟接种和拒绝接种）、疫苗犹豫的决定因素（自满、便利性和信心）以及支付意愿。对年龄≥18岁的泰国普通人群进行了调查。在705名受访者中，10.4%表示犹豫，主要决定因素是对疫苗的自满程度低和信心不足；便利性低不是一个显著的决定因素。多因素分析显示，女性、受过高等教育者、非医护人员以及居住在农村地区的人群存在疫苗犹豫情况。此外，77.2%的受访者愿意支付，大多数人愿意每剂支付501 - 1000泰铢（1美元 = 33泰铢）。月收入增加、新冠疫情对收入无影响以及时间段（在mRNA疫苗可用之前）对支付意愿有显著影响。
